Aquilo Capital Management, LLC

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return0%0%0%0%0%
Purchase Success Rate0 of 40 of 40 of 40 of 40 of 4
Average Sale Return(9%)5%0%0%0%
Sale Success Rate0 of 41 of 40 of 40 of 40 of 4

Pieris Pharmaceuticals, Inc.

Drugs » Biotechnology

10% Owner:

Holdings: 3.68M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Spero Therapeutics, Inc.

Other » Other

10% Owner:

Holdings: 3.42M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--